# Astrana Health (ASTH) — Earnings

ASTH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/asth/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.40 |
| EPS estimate | $0.34 |
| EPS surprise | +19.12% |
| Revenue surprise | −1.33% |
| Revenue | $972.5M |
| Revenue estimate | $985.6M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1083446/000119312526342631/asth-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/ee6a4763-bc39-7809-0287-b4b181cf4830.html) |

Astrana Health reported Q2 2026 results on August 6, 2026. Earnings per share were $0.40, ahead of the $0.34 estimate by 19.12%. Revenue was $972.5 million, 1.33% below the $985.6 million consensus. Compared with Q2 2025, EPS roughly doubled from $0.19 and revenue grew 48.5% from $654.8 million. Revenue was the highest in the table.

The 20 quarters shown tell two different stories. Revenue grew fast: from $1.14 billion in 2022 to $1.39 billion in 2023, $2.03 billion in 2024 and $3.18 billion in 2025, with the biggest step in Q3 2025. Earnings did not keep pace. Annual EPS was $1.06 in 2022 and $1.32 in 2023, then fell to $0.89 in 2024 and $0.46 in 2025. Astrana posted losses in Q4 2022 and Q4 2024, and Q3 2025 earned just $0.01 against a $0.47 estimate. The first half of 2026 adds up to $0.69 per share. Over the 20 quarters, Astrana beat the EPS estimate 14 times and missed 6 times.

Astrana has reported its third-quarter results between November 3 and November 7 in each of the past five years. That points to early November 2026 for Q3 2026. It will show whether earnings keep rising with revenue.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.34 | $0.40 | 19.12% | $985.6M | $972.5M |
| Q1 2026 | May 7, 2026 | $0.30 | $0.29 | -2.91% | $949.2M | $965.1M |
| Q4 2025 | Mar 2, 2026 | $0.11 | $0.12 | 6.67% | $930.4M | $950.5M |
| Q3 2025 | Nov 6, 2025 | $0.47 | $0.01 | -97.86% | $952.8M | $956.0M |
| Q2 2025 | Aug 7, 2025 | $0.35 | $0.19 | -45.54% | $638.3M | $654.8M |
| Q1 2025 | May 8, 2025 | $0.21 | $0.14 | -32.37% | $630.7M | $620.4M |
| Q4 2024 | Feb 27, 2025 | $0.10 | −$0.15 | -251.52% | $617.2M | $665.2M |
| Q3 2024 | Nov 7, 2024 | $0.31 | $0.33 | 6.73% | $462.4M | $478.7M |
| Q2 2024 | Aug 7, 2024 | $0.39 | $0.40 | 1.91% | $447.5M | $486.3M |
| Q1 2024 | May 7, 2024 | $0.30 | $0.31 | 2.48% | $413.8M | $404.4M |
| Q4 2023 | Feb 27, 2024 | $0.15 | $0.26 | 76.03% | $341.2M | $353.0M |
| Q3 2023 | Nov 7, 2023 | $0.33 | $0.47 | 42.42% | $349.5M | $348.2M |
| Q2 2023 | Aug 7, 2023 | $0.25 | $0.28 | 12.40% | $342.0M | $348.2M |
| Q1 2023 | May 8, 2023 | $0.31 | $0.31 | 1.08% | $318.1M | $337.2M |
| Q4 2022 | Feb 23, 2023 | −$0.07 | −$0.06 | 14.29% | $247.3M | $294.2M |
| Q3 2022 | Nov 3, 2022 | $0.32 | $0.56 | 75.82% | $269.6M | $317.0M |
| Q2 2022 | Aug 4, 2022 | $0.20 | $0.25 | 23.15% | $243.8M | $269.7M |
| Q1 2022 | May 5, 2022 | $0.32 | $0.31 | -3.13% | $225.3M | $263.3M |
| Q4 2021 | Feb 24, 2022 | $0.27 | $0.30 | 13.21% | $176.2M | $195.1M |
| Q3 2021 | Nov 4, 2021 | $0.34 | $0.74 | 117.65% | $189.1M | $227.1M |

## Frequently Asked Questions

### When did Astrana Health (ASTH) last report earnings?

Astrana Health last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did ASTH beat earnings estimates?

Yes. Astrana Health reported EPS of $0.40 for Q2 2026 against a $0.34 estimate — a 19.12% beat.

### How much revenue did ASTH report last quarter?

Astrana Health reported $972.5M in revenue for Q2 2026, against a consensus estimate of $985.6M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).